MAY 12, 2016 12:43 PM PDT

"Hide and Seek" Between Cancer and Immune Cells

WRITTEN BY: Kara Marker
Cancer cells are mutated cells that grow abnormally. Cytotoxic T cells of the immune system are designed and developed to recognize the abnormal parts and target these cells for destruction. Cancer cells are capable of evolving mechanisms for “hiding” from the immune system, though, and current immunotherapies used in conjunction with chemotherapy are designed to help boost the efficiency and success of the immune system to “seek” out cancer cells.

More than 12 million people per year are diagnosed with cancer, and a new study from the Texas A&M Health Science Center provides doctors a leg-up on cancer cells during this game of hide-and-seek by discovering a specific mechanism cancer cells incorporate to stay hidden.
 

Cancer cells that are equipped to remain hidden from the immune system often block the activity of a gene called NLRC5. This gene is responsible for regulating major histocompatibility complex (MHC) class I genes that cytotoxic T cells rely on for recognizing cancer cells. Prompted by NLRC5 regulation, MHC class I genes create molecules that sit on the surface of cancer-ridden cells waving a microscopic red flag to get the attention of circulating T cells.

Without NLRC5, T cells passing by a population of cancer cells would be completely unaware of that they were dangerous, abnormally growing cells. Disrupting the natural “anti-tumor” system is extremely dangerous, as tumors can then grow and metastasize uninhibited, and a person with this growing tumor might not be aware of their cancer until a very late stage.

In a study of 7747 biopsy samples from cancer patients enrolled in The Cancer Genome Atlas (TCGA) database, Texas A&M researchers pinpointed the precise relationship between NLRC5 expression and cancer patient survival. The longest survivors had the highest expression of NLRC5, and vice-versa.  

"We found that function and expression of NLRC5 is reduced in cancer cells by various mechanisms, and the result is immune evasion by cancer cells,” said first author Sayuri Yoshihama, MD, PhD.

NLRC5 was especially indicative of cancer patient outcomes in cases of melanoma, rectal cancer, bladder cancer, cervical cancer, and head/neck cancer. Melanoma in particular showed a 36 percent 5-year survival rate in low NLRC5 expression groups and 71 percent survival in high expression groups. Similarly, bladder cancer patients’ survival was closely related to NLRC5 levels, showing 34 percent survival with low expression of the gene and 62 percent with high expression.

The correlation between NLRC5 and cancer patient outcomes is promising to scientists and doctors who are pursuing more accurate prognoses and, eventually, better treatment options.

"No other mechanism [of cancer evading the immune system] is as dramatic as we found,” said Koichi Kobayashi, MD, PhD, lead author of the study.  

This study was recently published in Proceedings of the National Academy of Sciences.
 

Source: Texas A&M University
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
MAR 31, 2021
Microbiology
Deep-Sea Microbes Are 'Invisible' to the Human Immune System
MAR 31, 2021
Deep-Sea Microbes Are 'Invisible' to the Human Immune System
Scientists took an exploratory journey to a place in the central Pacific Ocean in Kirbati called the Phoenix Islands Pro ...
APR 11, 2021
Genetics & Genomics
Trial Shows Personalized Cancer Vaccines are Safe
APR 11, 2021
Trial Shows Personalized Cancer Vaccines are Safe
Vaccines are mostly known as tools to prevent illness. But cancer vaccines are a bit different, and aim to treat existin ...
APR 19, 2021
Cell & Molecular Biology
Insight Into the Molecular Basis of Rheumatoid Arthritis
APR 19, 2021
Insight Into the Molecular Basis of Rheumatoid Arthritis
New research has shown how variants in an immune gene can lead to a high risk of developing the autoimmune disorder rheu ...
MAY 10, 2021
Coronavirus
Researchers Create a Vaccine For Multiple SARS Viruses, Including COVID-19 & Variants
MAY 10, 2021
Researchers Create a Vaccine For Multiple SARS Viruses, Including COVID-19 & Variants
The pandemic virus SARS-CoV-2 has changed the world in devastating ways, taking hundreds of thousands of lives & new var ...
MAY 18, 2021
Immunology
Pizza's (Temporary) Effect on the Immune System
MAY 18, 2021
Pizza's (Temporary) Effect on the Immune System
Too much salt isn’t good for you—we know that it can contribute to elevated blood pressure, cardiovascular a ...
JUL 05, 2021
Health & Medicine
No Rise in Acid-Related Diseases After Reduction of PPI Use
JUL 05, 2021
No Rise in Acid-Related Diseases After Reduction of PPI Use
In a study including several million veterans as participants, researchers at the University of Michigan found that an i ...
Loading Comments...